Data / Drug companies / Sertraline hydrochloride
Sertraline hydrochloride: 55 companies and 194 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sertraline hydrochloride is listed in the FDA National Drug Code Directory by 55 companies, with 194 products in commercial distribution. 185 of the products (95.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; capsule, and the newest product started marketing on October 16, 2026.
The request: Get every company that lists sertraline hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 55
- Products
- 194
- Generic (ANDA) products
- 185 (95.4%)
- Application numbers
- 18
- Routes
- Oral
- Brand names
- Zoloft, Sertraline HCl, Sertraline HCl, Finjozy, Sertraline
- openFDA record search
- api.fda.gov
Companies that list sertraline hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 22 | tablet, film coated; tablet | Generic drugs (ANDA) | August 6, 2025 |
| Bryant Ranch Prepack | 13 | tablet, film coated; tablet | Generic drugs (ANDA) | August 6, 2025 |
| Remedyrepack Inc. | 10 | tablet, film coated; tablet | Generic drugs (ANDA) | July 21, 2026 |
| Preferred Pharmaceuticals Inc. | 7 | tablet, film coated | Generic drugs (ANDA) | July 15, 2026 |
| Coupler LLC | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | July 10, 2026 |
| Lupin Pharmaceuticals, Inc. | 6 | tablet, film coated | Generic drugs (ANDA) | August 6, 2025 |
| NuCare Pharmaceuticals,Inc. | 6 | tablet, film coated; tablet | Generic drugs (ANDA) | May 3, 2021 |
| Cipla USA Inc. | 5 | tablet; capsule | Generic drugs (ANDA) | July 17, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | February 6, 2007 |
| Proficient Rx LP | 5 | tablet, film coated | Generic drugs (ANDA) | February 9, 2017 |
| Aurobindo Pharma Limited | 4 | tablet, film coated; solution, concentrate | Generic drugs (ANDA) | October 31, 2008 |
| Cardinal Health 107, LLC | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | April 3, 2017 |
| NorthStar Rx LLC | 4 | tablet, film coated; solution | Generic drugs (ANDA) | October 31, 2008 |
| St. Mary's Medical Park Pharmacy | 4 | tablet, film coated | Generic drugs (ANDA) | August 15, 2024 |
| Viatris Specialty LLC | 4 | tablet, film coated; solution, concentrate | New drug applications (NDA) | July 8, 2025 |
| Accord Healthcare Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 9, 2017 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | June 19, 2017 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | February 9, 2017 |
| Ascent Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | May 3, 2021 |
| Asclemed USA, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | February 6, 2007 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | November 20, 2025 |
| AvPAK | 3 | tablet, film coated | Generic drugs (ANDA) | October 9, 2025 |
| Camber Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | May 3, 2021 |
| Granules Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | May 15, 2023 |
| Legacy Pharmaceutical Packaging, LLC | 3 | tablet | Generic drugs (ANDA) | July 21, 2016 |
| Major Pharmaceuticals | 3 | tablet, film coated | Generic drugs (ANDA) | February 6, 2007 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 3 | tablet, film coated | Generic drugs (ANDA) | February 6, 2007 |
| Northwind Health Company, LLC | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | June 17, 2020 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet; tablet, film coated | Generic drugs (ANDA) | February 9, 2017 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | July 21, 2016 |
| ScieGen Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | May 8, 2023 |
| Unit Dose Solutions, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | July 8, 2026 |
| XLCare Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | May 3, 2021 |
| Advanced Rx of Tennessee, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | April 7, 2023 |
| Almatica Pharma LLC | 2 | capsule | New drug applications (NDA) | October 4, 2021 |
| Alvogen Inc. | 2 | capsule | Authorized generics (NDA) | September 18, 2025 |
| Ani Pharmaceuticals, Inc. | 2 | capsule | Generic drugs (ANDA) | January 20, 2026 |
| Biocon Pharma Inc. | 2 | capsule | Generic drugs (ANDA) | January 30, 2026 |
| Bryant Ranch Prepack | 2 | tablet, film coated | Generic drugs (ANDA) | February 6, 2007 |
| Dr. Reddy's Laboratories Inc. | 2 | capsule | Generic drugs (ANDA) | January 15, 2026 |
| QPharma, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | February 9, 2017 |
| Quallent Pharmaceuticals Health LLC | 2 | tablet, film coated | Generic drugs (ANDA) | September 28, 2023 |
| TruPharma, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | October 16, 2026 |
| Umedica Laboratories USA Inc. | 2 | capsule | Generic drugs (ANDA) | February 15, 2026 |
| Zydus Lifesciences Limited | 2 | capsule | Generic drugs (ANDA) | January 29, 2026 |
| Zydus Pharmaceuticals USA Inc. | 2 | capsule | Generic drugs (ANDA) | January 29, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | February 6, 2007 |
| Bryant Ranch Prepack | 1 | solution | Generic drugs (ANDA) | June 30, 2006 |
| Direct_Rx | 1 | tablet, film coated | Generic drugs (ANDA) | July 29, 2020 |
| Method Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | October 15, 2026 |
| Mylan Pharmaceuticals Inc. | 1 | solution, concentrate | Authorized generics (NDA) | May 15, 2018 |
| Northwind Health Company, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | February 11, 2026 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | August 6, 2025 |
| Quality Care Products, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | February 6, 2007 |
| Rising Pharma Holdings, Inc. | 1 | solution, concentrate | Generic drugs (ANDA) | October 31, 2008 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 132 | 68% |
| Tablet | 38 | 19.6% |
| Capsule | 18 | 9.3% |
| Solution, concentrate | 4 | 2.1% |
| Solution | 2 | 1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 185 | 95.4% |
| New drug applications (NDA) | 6 | 3.1% |
| Authorized generics (NDA) | 3 | 1.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Serotonin Reuptake Inhibitor | 194 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.